Skip to content
10-Q

Quarterly Report

ANGIOGENEX, INC.

0001469709-17-000278

← back to feed
Filed
Nov 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 10, 2017 29.39M sh
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$397.34K
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$82.73K
Cash And Equivalents Q3 2017 · Sep 30, 2017 $625.13K
Cash And Equivalents Q3 2017 · Sep 30, 2016 $23.16K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $886
Current Liabilities Q3 2017 · Sep 30, 2017 $1.24M
Current Liabilities Q3 2017 · Dec 31, 2016 $995.83K
Current Assets Q3 2017 · Sep 30, 2017 $655.73K
Current Assets Q3 2017 · Dec 31, 2016 $272.47K
Total Assets Q3 2017 · Sep 30, 2017 $655.73K
Total Assets Q3 2017 · Dec 31, 2016 $272.47K
Sga Expense Q3 2017 · Sep 30, 2016 $126.39K
Sga Expense Q3 2017 · Sep 30, 2016 $376.61K
Rd Expense Q3 2017 · Sep 30, 2016 $14.04K
Rd Expense Q3 2017 · Sep 30, 2016 $68K
Net Income Q3 2017 · Sep 30, 2016 −$143.23K
Net Income Q3 2017 · Sep 30, 2016 −$452.84K
Operating Income Q3 2017 · Sep 30, 2016 −$140.43K
Operating Income Q3 2017 · Sep 30, 2016 −$444.61K